scholarly journals EP.TH.632A single centre’s experience with bariatric surgery outcomes compared to UK NBSR third report 2020

2021 ◽  
Vol 108 (Supplement_7) ◽  
Author(s):  
Georgina James ◽  
Bussa Gopinath ◽  
Milind Rao
Keyword(s):  
Bariatric Surgery ◽  
Weight Loss ◽  
Average Weight ◽  
Patient Records ◽  
Gastric Sleeve ◽  
Electronic Patient Records ◽  
Period Data ◽  
Surgery Outcomes ◽  
Specialist Nurses ◽  
The Uk

Abstract Bariatric Surgery has become a routine elective operation offered to patients with obesity (BMI >30) and obesity related diseases. The UK national Bariatric Surgery registry (NBSR) publishes data from record bariatric surgeries. Aim We compare one Bariatric service’s outcomes with the outcomes of the NBSR- Third Report 2020. Outcomes; 30-day mortality and complications, length of stay (LOS), 1-year weight loss for Gastric Sleeve (GS) and Roux-en-Y gastric bypasses. Method We collected data from one bariatric unit over a 98-month period. Data were taken from bariatric specialist nurses and electronic patient records. This was then compared with the NBSR report 2020. Results NBSR UK records 48.8% bypasses and 35.4% GS compared with our department (81.2% bypasses and 9.5% GS.) The average weight-loss 1-year post op for GS 36.9kg (NBSR 40.3kg) and for bypass 60.2kg (NBSR 44.1 kg) The average LOS for Bypass was 2.37 days (95%CI 2.3-.2.7) compared with the NBSR 2.6 (95% CI: 2.5-2.7). Whereas GS 2.9 (95%CI: 2.3-3.4) compared to NBSR 2.5 (95% CI: 2.4-2.6). 30-day mortality for primary procedures was 0% for Bypasses and GS compared with the NBSR 0.05%. 30 day complications at 1.74% compared with NBSR <2.38%. Conclusion Our unit proportionally performs more bypasses compared with the rest of UK and has greater 1-year weight-Loss with bypass procedures. This bariatric unit had less 30 day mortality and complications compared with NBSR. Our department is meeting the national outcomes when compared with the rest of the UK.

scholarly journals Sex disparity in laparoscopic bariatric surgery outcomes: a matched-pair cohort analysis

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Pouria Mousapour ◽  
Erfan Tasdighi ◽  
Alireza Khalaj ◽  
Maryam Mahdavi ◽  
Majid Valizadeh ◽  
...  
Keyword(s):  
Bariatric Surgery ◽  
Weight Loss ◽  
Postoperative Complications ◽  
Cohort Analysis ◽  
Operation Time ◽  
Matched Pair ◽  
Laparoscopic Bariatric Surgery ◽  
Men And Women ◽  
Preoperative Body Mass Index ◽  
Surgery Outcomes

AbstractMen have been historically considered to be higher-risk patients for bariatric surgery compared to women, the perception of which is suggested to be a barrier to bariatric surgery in men. The purpose of this study is to conduct a matched-pair analysis to evaluate sex disparities in laparoscopic bariatric surgery outcomes. Data on patients who underwent laparoscopic bariatric surgery from March 2013 to 2017 was collected prospectively. Then, 707 men and 707 women pair-matched for age, preoperative body mass index (BMI) and the procedure type (i.e., sleeve gastrectomy, Roux-en-Y, or one-anastomosis gastric bypass) were compared in terms of weight loss, remission of obesity-related comorbidities, and postoperative complications classified according to the Clavien–Dindo classification. There was no difference between the two sexes regarding the operation time, bleeding during surgery and length of postoperative hospital stay. We observed similar total weight loss, BMI loss, and percentage of excess BMI loss at 12, 24, and 36 months postoperatively between men and women, with no difference in remission of diabetes mellitus, hypertension and dyslipidemia at 12 months. The rate of in-hospital, 30-day and late complications according to Clavien–Dindo classification grades was similar between men and women. Our matched-pair cohort analysis demonstrated that bariatric surgery results in comparable short- and mid-term efficacy in men and women, and is associated with similar rate and severity of postoperative complications between sexes. These findings suggest bariatric surgeons not to consider sex for patient selection in bariatric surgery.

Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? A pilot randomized study

2011 ◽  
Vol 26 (3) ◽  
pp. 853-861 ◽  
Author(s):  
Manish Parikh ◽  
Meena Dasari ◽  
Michelle McMacken ◽  
Christine Ren ◽  
George Fielding ◽  
...  
Keyword(s):  
Bariatric Surgery ◽  
Weight Loss ◽  
Randomized Study ◽  
Weight Loss Program ◽  
Surgery Outcomes

The Influence of Resected Gastric Weight upon Weight Loss after Sleeve Gastrectomy

2015 ◽  
Vol 81 (12) ◽  
pp. 1240-1243 ◽  
Author(s):  
Ulysses Rosas ◽  
Harrison Hines ◽  
Daniel Rogan ◽  
Homero Rivas ◽  
John Morton
Keyword(s):  
Bariatric Surgery ◽  
Weight Loss ◽  
Sleeve Gastrectomy ◽  
Surgical Intervention ◽  
Excess Weight Loss ◽  
Resected Stomach ◽  
Gastric Sleeve ◽  
Improved Outcomes ◽  
Resected Tissue

Bariatric surgery is an effective and enduring treatment for obesity. Sleeve gastrectomy (SG) has emerged as an increasingly prevalent surgical intervention. Further investigation is required to determine optimal standardization of SG. Data were collected prospectively for 64 patients who underwent a laparoscopic vertical SG between December 2010 and February 2013 at a single academic institution. Demographic, intraoperative, and postoperative (postop) data were collected for all patients including weighing each resected stomach. The total resected gastric weight varied widely. Preoperatively, patients in the upper tercile for resected gastric weight were more likely to be male (lower 10%, middle 23%, upper 52%, P = 0.006) and had greater initial weights (lower 255.9%, middle 245.1%, upper 280.0%, P = 0.019). The resected gastric weight (g) varied by tercile (mean of all, 131.24 ± 39.8; lower, 93.9 ± 10.9; middle, 127.4 ± 11.7; upper 172.7 ± 37.9, P = 0.000). Patients were followed for 1-year postop with follow-up data for 94 per cent (60/64) of participants. Per cent excess weight loss (EWL) was obtained at three, six, and 12 months postop. At 12 months, there was a trend toward increased per cent EWL in the upper tercile (lower 61.1%, middle 54.1%, upper 90.5%, P = 0.057). In conclusion, while the amount of gastric sleeve resected can vary, this study shows that intraoperative assessment of resected sleeve weight can help evaluate adequacy of resection. Improved 12-month per cent EWL in patients with greater resected tissue demonstrate potentially improved outcomes.

scholarly journals Effect of Gastrointestinal Surgical Manipulation on Metabolic Syndrome: A Focus on Metabolic Surgery

2012 ◽  
Vol 2012 ◽  
pp. 1-10 ◽  
Author(s):  
Mario Rizzello ◽  
Francesco De Angelis ◽  
Fabio Cesare Campanile ◽  
Gianfranco Silecchia
Keyword(s):  
Bariatric Surgery ◽  
Metabolic Syndrome ◽  
Weight Loss ◽  
Cochrane Library ◽  
Increased Risk ◽  
Effective Option ◽  
Surgery Outcomes ◽  
The Cochrane Library ◽  
Surgical Manipulation ◽  
Related Mortality

Metabolic syndrome is strictly associated with morbid obesity and leads to an increased risk of cardiovascular diseases and related mortality. Bariatric surgery is considered an effective option for the management of these patients. We searched MEDLINE, Current Contents, and the Cochrane Library for papers published on bariatric surgery outcomes in English from 1 January 1990 to 20 July 2012. We reported the effect of gastrointestinal manipulation on metabolic syndrome after bariatric surgery. Bariatric surgery determines an important resolution rate of major obesity-related comorbidities. Roux-en-Y gastric bypass and biliopancreatic diversion appear to be more effective than adjustable gastric banding in terms of weight loss and comorbidities resolution. However, the results obtained in terms of weight loss and resolution of comorbidities after a “new bariatric procedure” (sleeve gastrectomy) encouraged and stimulated the diffusion of this operation.

scholarly journals Extraoral Halitosis due to Exhaled Acetone in Patients Undergoing Sleeve Gastrectomy

2021 ◽  
Author(s):  
Hanadi Alzahrani ◽  
Mohammed A AlSarhan ◽  
Abdullah Aldohayan ◽  
Fahad Bamehriz ◽  
Hamad A Alzoman
Keyword(s):  
Bariatric Surgery ◽  
Weight Loss ◽  
Sleeve Gastrectomy ◽  
High Rate ◽  
Rapid Weight Loss ◽  
Gastric Sleeve ◽  
Blood Samples ◽  
Gastric Sleeve Surgery ◽  
The Mean ◽  
Breath Acetone

Introduction: Bariatric surgery is widely used and considered as one of the most effective treatments for morbid obesity, but it can be associated with medical and dental adverse side-effects. It is frequently associated with major metabolic changes that may lead to extraoral halitosis. Aim: To assess the role of exhaled acetone produced as a result of weight loss in the production of extra-oral halitosis in patients undergoing bariatric surgery. Materials and Methods: A prospective longitudinal cohort study was designed from October 2018 to November 2019 and monitored for six months postsurgery. The subjects were patients undergoing sleeve gastrectomy surgery with a Body Mass Index (BMI) of 35-50 kg/m2. Subjects were divided into two groups of low BMI loss (<5 Kg/m2) and high BMI loss (≥5 Kg/m2) postsurgery, Breath samples were collected with a portable breath ketone analyser for measurement of acetone concentrations, and blood samples were taken for measurement of 3-hydroxybutyrate levels. Breath and blood samples were taken at baseline then at one month, three months, and six months postsurgery. All statistical analysis were performed using the SPSS version 22.0 with a significance value of p-value set at p<0.05. Results: Out of 43 patients enrolled initially, eventually 39 patients completed the study. The mean level of breath acetone was 4.1, 3.4, and 3.8 ppm at one month, three months, and six months, respectively (p=0.018). There was a statistically significant increase in breath acetone at one month in patients with a high rate of BMI loss. At one month, the mean blood level of 3-hydroxybutyrate was higher in patients with a high rate of BMI loss than in those with a low rate of BMI loss (1.9 vs. 1.2 mmol/L; p=0.049). The levels of breath acetone and blood 3-hydroxybutyrate were significantly correlated at one month (r=0.6, p<0.05). Conclusion: Rapid weight loss one month after gastric sleeve surgery resulted in high acetone levels suggestive of increased extraoral halitosis in such patients. Increased Acetone levels in breath and 3-hydroxybutyrate in blood are suggestive of increased extraoral halitosis in patients undergoing gastric sleeve surgery particularly within a month after surgery.

scholarly journals Effectiveness of Gastric Bypass Versus Gastric Sleeve for Cardiovascular Disease: Protocol and Baseline Results for a Comparative Effectiveness Study

10.2196/14936 ◽  
2020 ◽  
Vol 9 (4) ◽  
pp. e14936
Author(s):  
Karen J Coleman ◽  
Heidi Fischer ◽  
David E Arterburn ◽  
Douglas Barthold ◽  
Lee J Barton ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Bariatric Surgery ◽  
Health Care ◽  
Weight Loss ◽  
Gastric Bypass ◽  
Cohort Study ◽  
Health Care System ◽  
Comparative Effectiveness ◽  
Gastric Sleeve

Background When compared with conventional weight loss strategies, bariatric surgery results in substantially greater durable weight loss and rates of disease remission. Objective The ENGAGE CVD (Effectiveness of Gastric Bypass versus Gastric Sleeve for Cardiovascular Disease) cohort study aimed to provide population-based, comprehensive, rigorous evidence for clinical and policy decision making regarding the choice between gastric bypass and gastric sleeve for overall cardiovascular disease (CVD) risk reduction, risk factor remission, and safety. Methods The cohort had 22,095 weight loss surgery patients from a large integrated health care system in Southern California assembled from 2009 to 2016 who were followed up through 2018. Bariatric surgery patients were followed up for the length of their membership in the health care system. Of the patients who had at least five years of follow-up (surgery between 2009 and 2013), 85.86% (13,774/16,043) could contribute to the outcome analyses for the ENGAGE CVD cohort. Results Patients in the ENGAGE CVD cohort were 44.6 (SD 11.4) years old, mostly women (17,718/22,095; 80.19%), with 18.94% (4185/22,095) non-Hispanic black and 41.80% (9235/22,095) Hispanic, and had an average BMI of 44.3 (SD 6.9) kg/m2 at the time of surgery. When compared with patients who did not contribute data to the 5-year outcome analysis for the ENGAGE CVD cohort (2269/16,043; 14.14%), patients who contributed data (13,774/16,043; 85.86%) were older (P=.002), more likely to be women (P=.02), more likely to be non-Hispanic white (P<.001), more likely to have had an emergency department visit in the year before surgery (P=.006), less likely to have a mental illness before surgery (P<.001), and more likely to have had a CVD event at any time before surgery (P<.001). Conclusions This study had one of the largest populations of gastric sleeve patients (n=13,459). The 5-year follow-up for those patients who had surgery between 2009 and 2013 was excellent for a retrospective cohort study at 85.86% (13,774/16,043). Unlike almost any study in the literature, the majority of the ENGAGE CVD cohort was racial and ethnic minority, providing a rare opportunity to study the effects of bariatric surgery for different racial and ethnic groups, some of whom have the highest rates of severe obesity in the United States. Finally, it also used state-of-the-art statistical and econometric comparative effectiveness methods to mimic the effect of random assignment and control for sources of confounding inherent in large observational studies. International Registered Report Identifier (IRRID) RR1-10.2196/14936

Predicting Early Weight Loss Failure Using a Bariatric Surgery Outcomes Calculator and Weight Loss Curves

2018 ◽  
Vol 14 (11) ◽  
pp. S33-S34
Author(s):  
Oliver A Varban ◽  
Anne Cain-Nielsen ◽  
Corey Lager ◽  
Nazanene Esfandiari ◽  
Elif Oral ◽  
...  
Keyword(s):  
Bariatric Surgery ◽  
Weight Loss ◽  
Weight Loss Failure ◽  
Surgery Outcomes ◽  
Early Weight Loss
Sign in / Sign up

Export Citation Format

Share Document